We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Macrolide resistance among invasive Streptococcus pneumoniae isolates.
- Authors
Hyde, T B; Gay, K; Stephens, D S; Vugia, D J; Pass, M; Johnson, S; Barrett, N L; Schaffner, W; Cieslak, P R; Maupin, P S; Zell, E R; Jorgensen, J H; Facklam, R R; Whitney, C G; Active Bacterial Core Surveillance/Emerging Infections Program Network
- Abstract
Macrolide antibiotics, including erythromycin, clarithromycin, and azithromycin, are the mainstays of empirical pneumonia therapy. Macrolide resistance among Streptococcus pneumoniae, the most common cause of community-acquired pneumonia, is increasing in the United States. Whether resistance is a significant problem or whether macrolides remain useful for treatment of most resistant strains is unknown.
- Publication
JAMA, 2001, Vol 286, Issue 15, p1857
- ISSN
0098-7484
- Publication type
Journal Article
- DOI
10.1001/jama.286.15.1857